Regression of Spontaneous Mammary Tumors in Rats by Ergot Drugs
Overview
General Medicine
Physiology
Authors
Affiliations
Astafeva L, Shishkina L, Kalinin P, Kadashev B, Melnichenko G, Tserkovnay D Asian J Neurosurg. 2020; 15(2):385-390.
PMID: 32656137 PMC: 7335146. DOI: 10.4103/ajns.AJNS_16_20.
Breast cancer in a male patient with prolactinoma.
Haga S, Watanabe O, Shimizu T, Iida T, Imamura H, Kajiwara T Surg Today. 1993; 23(3):251-5.
PMID: 8385514 DOI: 10.1007/BF00309236.
Characteristics of 106 spontaneous mammary tumours appearing in Sprague-Dawley female rats.
Okada M, Takeuchi J, Sobue M, Kataoka K, Inagaki Y, Shigemura M Br J Cancer. 1981; 43(5):689-95.
PMID: 7248153 PMC: 2010671. DOI: 10.1038/bjc.1981.100.
Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.
Muller E, Locatelli V, Cella S, Penalva A, Novelli A, Cocchi D Drugs. 1983; 25(4):399-432.
PMID: 6133737 DOI: 10.2165/00003495-198325040-00004.
Suppression of puerperal lactation with an ergot alkaloid: a double-blind study.
Varga L, Lutterbeck P, PRYOR J, WENNER R, Erb H Br Med J. 1972; 2(5816):743-4.
PMID: 4556543 PMC: 1788467. DOI: 10.1136/bmj.2.5816.743.